D-Wave Quantum's Trading Volume Plummets 52.26% to 141st Position Despite Quantum Computing Breakthroughs

On May 12, 2025, D-Wave Quantum (QBTS) experienced a significant decline in trading volume, with a total turnover of $84.4 million, marking a 52.26% decrease from the previous day. This placed D-Wave Quantum at the 141st position in terms of trading volume among all stocks for the day. The stock price of D-Wave Quantum (QBTS) decreased by 3.34%.

D-Wave Quantum's CEO, Dr. Alan Baratz, recently appeared on Fox Business' The Claman Countdown to discuss the company's latest advancements in quantum computing. He highlighted that D-Wave's Advantage2 quantum computer has demonstrated quantum supremacy by outperforming one of the world's top supercomputers in complex materials simulation. This breakthrough has garnered attention from supercomputer communities and national laboratories globally. Dr. Baratz also mentioned that D-Wave's quantum systems are priced between $20-$40 million, with extended sales cycles. The company is positioning its annealing quantum computing technology as a key driver for accelerating commercial adoption, particularly for optimization problems in enterprise applications.

D-Wave Quantum reported exceptional first-quarter 2025 results, achieving record quarterly revenue of $15 million, a 509% year-over-year increase. The company also recorded a GAAP gross profit of $13.9 million and maintained a strong cash position of $304.3 million. Notable achievements include the first sale of an Advantage™ system to a research institution and the demonstration of quantum supremacy in a real-world problem. Ford Otosan successfully deployed a hybrid-quantum application, reducing vehicle scheduling time by 83%, and Japan Tobacco collaborated with D-Wave in drug discovery. The company expanded its customer base to 133, including 69 commercial customers, despite increased operating expenses of $25.2 million. D-Wave significantly reduced its net loss to $5.4 million ($0.02 per share) from $17.3 million in the first quarter of 2024.

D-Wave Quantum and Davidson Technologies have completed the physical assembly of Alabama's first on-site Advantage2™ annealing quantum computer at Davidson's Huntsville headquarters. The system is currently undergoing final calibration and readiness testing. This milestone positions Alabama as a key contributor to U.S. quantum infrastructure, with the system being housed in a secure facility designed for sensitive quantum computing applications. The installation follows a multi-year agreement between the companies, focusing on developing quantum optimization applications for national defense. Davidson plans to utilize the system for various defense applications, including multi-domain operational optimization, space asset management, and autonomous system coordination. The installation will be celebrated with a VIP ribbon-cutting event on April 23, attended by state and federal dignitaries.

D-Wave Quantum and Japan Tobacco's pharmaceutical division have successfully completed a groundbreaking proof-of-concept project combining quantum computing with AI for drug discovery. The project demonstrated that Large Language Models (LLMs) enhanced with D-Wave's quantum-hybrid workflow outperformed classical computing methods in generating novel drug-like molecular structures. Key findings show that the quantum-hybrid AI system produced more valid molecules with higher drug-likeness compared to traditional approaches. The collaboration utilized D-Wave's annealing quantum computing technology within JT's AI framework to train transformer architecture models, similar to ChatGPT, for exploring chemical space. The successful proof-of-concept validates quantum computing's potential to enhance AI capabilities while offering more energy-efficient solutions. Japan Tobacco plans to further advance this Quantum AI-driven drug discovery technology for molecular design.